Ls. Cook et al., A POPULATION-BASED STUDY OF CONTRALATERAL BREAST-CANCER FOLLOWING A FIRST PRIMARY BREAST-CANCER (WASHINGTON, UNITED-STATES), CCC. Cancer causes & control, 7(3), 1996, pp. 382-390
To evaluate predictors of contralateral breast cancer risk,we examined
data from a nested case-control study of second primary cancers among
a cohort of women in western Washington (United States) diagnosed wit
h breast cancer during 1978 through 1990 and identified through a popu
lation-based cancer registry. Cases included all women in the cohort w
ho subsequently developed contralateral breast cancer at least six mon
ths after the initial diagnosis, but prior to 1992 (n = 234). Controls
were sampled randomly from the cohort, matched to cases on age, stage
, and year of initial breast cancer diagnosis. Information on potentia
l risk factors for second primary cancer was obtained through medical
record abstractions and physician questionnaires, Women who were postm
enopausal due to a bilateral oophorectomy (i.e., a surgical menopause)
at initial breast cancer diagnosis had a reduction in contralateral b
reast cancer risk compared with premenopausal women (matched odds rati
o [mOR] = 0.25, 95 percent confidence interval [CI] = 0.09-0.68), wher
eas no reduction in risk was noted among postmenopausal women who had
had a natural menopause (mOR = 0.90, CI = 0.39-2.09). Among postmenopa
usal women, there was a suggestion of a lower risk associated with rel
atively high parity (2+). A family history of breast cancer was associ
ated with an increased risk (mOR = 1.96, CI = 1.22-5.15) and varied li
ttle by menopausal status, Having an initial tumor with a lobular comp
onent (c.f. a ductal histology) was not related strongly to risk (mOR
= 1.47, CI = 0.79-2.74), The results of the present and earlier studie
s argue that we have limited ability to predict the occurrence of a co
ntralateral breast tumor. Better predictors will be required before di
agnostic and preventive interventions can be targeted to subgroups of
patients with unilateral breast cancer.